Water dispersible pH-responsive chitosan nanogels modified with biocompatible crosslinking-agents

被引:59
作者
Arteche Pujana, Maite [1 ]
Perez-Alvarez, Leyre [1 ]
Cesteros Iturbe, L. Carlos [1 ]
Katime, Issa [1 ]
机构
[1] Univ Pais Vasco UPV EHU, Fac Ciencia & Tecnol, Dept Quim Fis, Grp Nuevos Mat & Espect Supramol, Bilbao 644, Spain
关键词
Chitosan; Nanogel; pH-responsive; LIGHT-SCATTERING; LINKED CHITOSAN; DRUG-DELIVERY; POLYMER NETWORKS; IN-VITRO; NANOPARTICLES; MICROEMULSION; ACETYLATION; CHITIN; MICROSPHERES;
D O I
10.1016/j.polymer.2012.05.027
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Chitosan nanoparticles were obtained by crosslinking with two biocompatible dicarboxylic acids: polyethylene glycol dicarboxylic acid and tartaric acid. The water-in-oil (W/O) microemulsion method yielded particle sizes around 10-15 nm in the dried state (TEM) and 200-700 nm in the swollen state (QELS) from commercial chitosan. All the synthesized nanogels showed improved water solubility and most of them were stable at physiological pH. QELS studies revealed the influence of the hydrophilic character and flexibility of the crosslinker on the swelling behaviour of the nanogels. The nanoparticles showed a pH-sensitive volume transition that was consistent with the pKa of chitosan. The collected zeta potential data corroborated the electrostatic repulsion mechanism responsible for the pH-responsive behaviour. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3107 / 3116
页数:10
相关论文
共 50 条
  • [1] Chitosan nanoparticles for prolonged delivery of timolol maleate
    Agnihotri, Sunil A.
    Aminabhavi, Tejraj M.
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (11) : 1254 - 1262
  • [2] The potential of chitosan in ocular drug delivery
    Alonso, MJ
    Sánchez, A
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (11) : 1451 - 1463
  • [3] Alonso MJ, 1998, Eur Patent, Patent No. [0860-166-A1, 19980860166]
  • [4] Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles
    Banerjee, T
    Mitra, S
    Singh, AK
    Sharma, RK
    Maitra, A
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 243 (1-2) : 93 - 105
  • [5] Beauchamp O, 1992, CRIT REV TOXICOL, V22, P143
  • [6] Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications
    Berger, J
    Reist, M
    Mayer, JM
    Felt, O
    Peppas, NA
    Gurny, R
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (01) : 19 - 34
  • [7] Preparation and characterization of chitosan-based nanoparticles
    Bodnar, M
    Hartmann, JF
    Borbely, J
    [J]. BIOMACROMOLECULES, 2005, 6 (05) : 2521 - 2527
  • [8] Synthesis and study of cross-linked chitosan-N-poly(ethylene glycol) nanoparticles
    Bodnar, Magdolna
    Hartmann, John F.
    Borbely, Janos
    [J]. BIOMACROMOLECULES, 2006, 7 (11) : 3030 - 3036
  • [9] CALVO P, 1997, J APPL POLYM SCI, V63, P25
  • [10] Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery
    Chan, Peggy
    Kurisawa, Motoichi
    Chung, Joo Eun
    Yang, Yi-Yan
    [J]. BIOMATERIALS, 2007, 28 (03) : 540 - 549